DESIR
Data Notes: Data from studies were split into two 50% samples, with data from the second sample censored at the prediction time. Data from both samples were used to derive the longitudinal models while data from the first sample was used to derive the Cox proportional hazards models. Risk prediction and validation were done using data from the second sample only. ( 
Web Figure 1B. Flow-chart showing the use of the study data in model derivation and validation

Total cholesterol
Adjusted for: sex, age, smoking status, history of diabetes, baseline systolic blood pressure, and baseline HDL cholesterol.
(Web Figure 3 continued: Regression dilution ratio graphs for systolic blood pressure, total cholesterol, and HDL cholesterol)
High-density lipoprotein (HDL) cholesterol
Adjusted for: sex, age, smoking status, history of diabetes, baseline systolic blood pressure, and baseline total cholesterol. Results are weighted by the number of CVD events in each study. Interpretation: e.g. for every one unit increase in the mean age of participants in a study, the difference in risk discrimination between Model 2 and Model 1 decreased by 0.0004 (-0.0007, 0.0000). Statistically significant results in bold.
Web
Web Table 6 . Reclassification of events and non-events in the validation data of the models Model 1 used baseline measures of systolic blood pressure, total cholesterol and HDL cholesterol. Model 2 used cumulative means of systolic blood pressure, total cholesterol and HDL cholesterol. Model 3 used individual-level random intercepts and slopes for systolic blood pressure, total cholesterol and HDL cholesterol. No difference in C-index between Model 2 and Model 1, and Model 3 and Model 1, could be calculated for the studies "CHARL" and "CAPS" (all participants in the validation sample were censored) and as such, these studies were excluded from the meta-analysis of change in C-index. Web Figure 9A . Changes in cardiovascular disease risk discrimination in each study in participants aged 40-69 years
Model 1 used baseline measures of systolic blood pressure, total cholesterol and HDL cholesterol. Model 2 used cumulative means of systolic blood pressure, total cholesterol and HDL cholesterol. Model 3 used individual-level random intercepts and slopes for systolic blood pressure, total cholesterol and HDL cholesterol. No difference in C-index between Model 2 and Model 1, and Model 3 and Model 1, were calculated for the studies "DRECE", "GOH", "ISRAEL", "PROCAM", "QUEBEC", and "WHITE2" (all participants in the validation sample were censored in one of the age groups) and as such, these studies were excluded from the meta-analysis of change in C-index. The study "DESIR" was not included in the analysis as no participants were aged 70 years or older. Model 1 used baseline measures of systolic blood pressure, total cholesterol and HDL cholesterol. Model 2 used cumulative means of systolic blood pressure, total cholesterol and HDL cholesterol. Model 3 used individual-level random intercepts and slopes for systolic blood pressure, total cholesterol and HDL cholesterol. No difference in C-index between Model 2 and Model 1, and Model 3 and Model 1, were calculated for the studies "DRECE", "GOH", "ISRAEL", "PROCAM" and "WHITE2" (all participants in the validation sample were censored in one of the age groups) and as such, these studies were excluded from the meta-analysis of change in C-index. The study "DESIR" was not included in the analysis as no participants were aged 70 years or older. 
